Source: Annual Congress 2003 - Lung function tests in childhood asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. M. Teper, G. Szulman, C. D. Kofman, F. Navarra, S. Zaragoza, S. Fernandez, C. Molise, A. F. Maffey, S. M. Vidaurreta (Buenos Aires, Argentina). Does fluticasone propionate (FP) improve pulmonary function in asthmatic infants?. Eur Respir J 2003; 22: Suppl. 45, 3108

Member's Comments

No comment yet.

Related content which might interest you: In vivo dose response relation of inhaled fluticasone propionate (FP), adults with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 132s Year: 2004 Comparison of fluticasone propionate + salmeterol (FP+S) and montelukast (MK) on bronchial reactivity (BR), pulmonary function (PF) and clinical outcome in children with mild asthma Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009 The effects of fluticasone propionate in asthmatic patients Source: Eur Respir J 2004; 24: Suppl. 48, 125s Year: 2004 Efficacy of fluticasone propionate on lung function and symptoms in wheezy infants Source: Eur Respir J 2004; 24: Suppl. 48, 464s Year: 2004 Airway hyperresponsiveness and treatment effectiveness during a one year study of the combination of salmeterol and fluticasone propionate (FP) compared with FP and salmeterol alone in mild to moderate asthma Source: Eur Respir J 2002; 20: Suppl. 38, 386s Year: 2002 The effect of fluticasone vs fluticasone plus salmeterol on allergen-induced bronchial inflammation in asthmatic patients. A long-term RCT Source: Eur Respir J 2004; 24: Suppl. 48, 125s Year: 2004 Dynamics of lung function in children treated with salmeterol/ fluticasone propionate combination (SFC) Source: Eur Respir J 2003; 22: Suppl. 45, 497s Year: 2003 Montelukast compared with fluticasone proprionate in children with persistent asthma Source: ISSN=ISSN 1810-6838, ISBN=, page=267 Year: 2006 Late Breaking Abstract - Dose responses for topical efficacy and systemic activity, dose equivalence and relative therapeutic index for fluticasone furoate (FF), fluticasone propionate (FP) and budesonide (BUD) in asthmatic subjects. Source: International Congress 2019 – New towards old therapies in airway diseases Year: 2019 Budesonide and formoterol in a single inhaler quickly gains asthma control compared with fluticasone propionate in mild asthma Source: Eur Respir J 2001; 18: Suppl. 33, 48s Year: 2001 Effect of switching from high dose fluticasone propionate (FP) to FP/salmeterol (FSC) on airway inflammation in asthma Source: Eur Respir J 2004; 24: Suppl. 48, 44s Year: 2004 Incentive for reduced variability in lung deposition of fluticasone propionate in young asthmatic children Source: Annual Congress 2008 - Wheezing in preschool children Year: 2008 Initiation of treatment with the salmeterol/fluticasone propionate (FP) combination product is better than inhaled steroid alone (FP) in asthmatic patients symptomatic on short-acting bronchodilator alone Source: Eur Respir J 2003; 22: Suppl. 45, 410s Year: 2003 Inhibition of allergen-iduced late asthmatic reaction by montelukast versus fluticasone propionate Source: Eur Respir J 2003; 22: Suppl. 45, 349s Year: 2003 Is low dose inhaled fluticasone propionate safe in young children with asthma? Source: Annual Congress 2008 - Preschool wheezing: advances in diagnosis, phenotyping and therapy Year: 2008 Response to fluticasone propionate in controlling airway inflammation in steroid-naïve asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 317s Year: 2006 Comparison of inhaled ciclesonide, fluticasone propinate and fluticasone propionate + salmeterol in maintaining asthma control Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009 Salmeterol/fluticasone propionate combination (SFC) improves airways hyperresponsiveness (AHR), lung function and symptoms in adult patients with mild asthma Source: Eur Respir J 2004; 24: Suppl. 48, 262s Year: 2004 The effects of treatment with fluticasone propionate alone and combination with salmeterol on asthma control and airway inflammation Source: Eur Respir J 2003; 22: Suppl. 45, 287s Year: 2003 Combination therapy with salmeterol and fluticasone propionate (SFC) is more effective than salmeterol (SAL) alone in reducing exacerbations of COPD Source: Eur Respir J 2005; 26: Suppl. 49, 292s Year: 2005